Coherus BioSciences falls after CFO resigns

Coherus Oncology

08/12/2023 13:52

** Shares of drugmaker Coherus BioSciences  CHRS.O  fall
7.8% to $2.12 premarket
    ** Late Thursday, co said CFO McDavid Stilwell has resigned
and will leave after Dec. 31
    ** CHRS will replace Stilwell on an interim basis in late
Dec or early Jan as it searches for new CFO      
    ** 7 of 9 brokerages rate stock "buy" or higher and 2
"hold"; their median PT is $11.5
    ** Up to Thursday's close, stock down 71% YTD 

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))